RadioMed Corporation, which founded in 1997 as a private corporation and now has become part of IBA since 2003. IBA is the worldwide technology leader in the field of proton therapy, the most advanced form of radiation therapy available today. VISICOIL, manufactured by RadioMed Corporation, is the original flexible linear marker for use with today’s most accurate image guided radiotherapy treatment plans. VISICOIL is a patented (US Patent 8,027,712) helically wound coil available in various diameters and lengths to aid in the treatment of a range of radiation therapy techniques that target the prostate, lung, liver, pancreas, breast and various other organs. VISICOIL’s flexible coiled markers allow for accurate tumor localization, using a variety of visualization techniques. VISICOIL is indicated for use to radiographically mark soft tissue for future therapeutic procedures, per US FDA cleared 510(K). Guided by VISICOIL, over 100,000 cancer patients worldwide have been treated with radiation therapy more safely and more accurately.
For more information visit: www.visicoil.com